- Home
- PKOH vs MREO Comparison
PKOH vs MREO Comparison
Compare PKOH & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKOH
- MREO
- Stock Information
- Founded
- PKOH 1907
- MREO 2015
- Country
- PKOH United States
- MREO United Kingdom
- Employees
- PKOH N/A
- MREO N/A
- Industry
- PKOH Industrial Specialties
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- PKOH Industrials
- MREO Health Care
- Exchange
- PKOH Nasdaq
- MREO Nasdaq
- Market Cap
- PKOH 299.9M
- MREO 326.1M
- IPO Year
- PKOH N/A
- MREO N/A
- Fundamental
- Price
- PKOH $20.34
- MREO $1.97
- Analyst Decision
- PKOH
- MREO Strong Buy
- Analyst Count
- PKOH 0
- MREO 5
- Target Price
- PKOH N/A
- MREO $7.40
- AVG Volume (30 Days)
- PKOH 31.0K
- MREO 1.3M
- Earning Date
- PKOH 11-05-2025
- MREO 11-11-2025
- Dividend Yield
- PKOH 2.48%
- MREO N/A
- EPS Growth
- PKOH 41.57
- MREO N/A
- EPS
- PKOH 2.02
- MREO N/A
- Revenue
- PKOH $1,611,500,000.00
- MREO $500,000.00
- Revenue This Year
- PKOH $0.23
- MREO N/A
- Revenue Next Year
- PKOH $3.07
- MREO $72.16
- P/E Ratio
- PKOH $9.98
- MREO N/A
- Revenue Growth
- PKOH N/A
- MREO N/A
- 52 Week Low
- PKOH $15.52
- MREO $1.47
- 52 Week High
- PKOH $34.50
- MREO $4.72
- Technical
- Relative Strength Index (RSI)
- PKOH 46.74
- MREO 57.79
- Support Level
- PKOH $20.04
- MREO $1.94
- Resistance Level
- PKOH $21.39
- MREO $2.12
- Average True Range (ATR)
- PKOH 0.88
- MREO 0.11
- MACD
- PKOH -0.18
- MREO 0.02
- Stochastic Oscillator
- PKOH 10.27
- MREO 62.65
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).